Thymosin Beta-4 also activates ILK (integrin-linked kinase), a key regulator of cell survival signaling downstream of integrins a mechanism discovered in the context of cardiac repair research
The high response rate to treatment with IBAT (odevixibat) in these patients suggests that in PFIC4, despite tight junction dysfunction, there is a regular passage of BAs from the hepatocytes to the biliary tree and the bowel, allowing odevixibat to interrupt the enterohepatic circulation and decrease the recirculating BA pool [1, 42, 47]
Open-label sulforaphane trial in FMR1 premutation carriers with fragile-x-associated tremor and ataxia syndrome (FXTAS)
It is responsible for the breakdown of complex and undigested polysaccharides, particularly mucin, resistant starch, and oligosaccharides, which the human body cannot metabolize on its own (151, 152)